Ameriprise’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.86M Buy
238,610
+33,556
+16% +$965K ﹤0.01% 2095
2025
Q1
$6.88M Sell
205,054
-150,120
-42% -$5.04M ﹤0.01% 2054
2024
Q4
$18.2M Buy
355,174
+186,681
+111% +$9.54M ﹤0.01% 1391
2024
Q3
$8.61M Buy
168,493
+143,695
+579% +$7.34M ﹤0.01% 1925
2024
Q2
$1.11M Buy
+24,798
New +$1.11M ﹤0.01% 3123